精密診断の世界市場

精密診断の世界市場は2030年までに498億米ドルに達する見込み

2024年に182億米ドルと推定された精密診断の世界市場は、2024～2030年の分析期間において18.3%のCAGRで成長し、2030年には498億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである遺伝子検査は、CAGR20.1%を記録し、分析期間終了時には263億米ドルに達すると予測されます。消費者への直接検査分野の成長率は、分析期間中CAGR14.9％と推定されます。

米国市場は50億米ドルと推定、中国はCAGR24.3％で成長予測

米国の精密診断市場は2024年に50億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに113億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは24.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.4%と16.6%と予測されています。欧州では、ドイツがCAGR約14.6%で成長すると予測されています。

世界の精密診断市場- 主要動向と促進要因のまとめ

なぜ精密診断がヘルスケアの未来を再形成するのか？

精密診断とは、多くの場合分子レベルまたは遺伝子レベルで、高精度の疾患検出を可能にする一連の先進医療技術を指します。従来の診断方法とは異なり、精密診断は遺伝子、ライフスタイル、環境における個人のばらつきに注目し、診断と治療戦略を患者一人一人に合わせる。このシフトにより、より早期の疾患特定、より優れたリスク層別化、より個別化された治療経路が可能となり、患者の転帰を大幅に改善し、治療の非効率性を減らすことができます。

がん、心血管疾患、自己免疫疾患などの複雑な疾患の世界の罹患率の増加は、より洗練された診断ツールに対する需要を加速させています。ヘルスケアシステムが予防と価値に基づくケアへと進化する中、精密診断はこの変革の要として台頭してきています。早期発見、予後予測、モニタリングにおける精密診断の役割は、疾病負担を軽減するだけでなく、タイムリーな介入を可能にすることであり、これは慢性的で生命を脅かす疾患にとって特に重要です。

技術の進歩と消費者の期待は市場にどのような影響を与えているか？

技術革新は急速に情勢を進展させています。ゲノムシークエンシング、分子プロファイリング、バイオマーカー解析の能力の向上により、疾病を最も早期かつ治療可能な段階で発見することが可能になりました。人工知能と機械学習を搭載したツールは現在、パターン認識を強化し、データ解釈を自動化し、リアルタイムの臨床的意思決定をサポートしています。こうした画期的な進歩により、診断の範囲とスピードが拡大し、より効果的でスケーラブルなものとなっています。

同時に、消費者の行動は、精密診断がどのようにデザインされ、提供されるかを形作りつつあります。今日の患者は、健康に対するリテラシーが高く、データに対する意識が高く、個別化された健康ソリューションに積極的です。リキッドバイオプシー、ウェアラブル健康機器、家庭用検査キットなど、非侵襲的な検査オプションへの関心が高まっています。このシフトは、ヘルスケアプロバイダーや診断薬を提供する企業に、正確性、スピード、利便性、プライバシーを兼ね備えた、よりユーザー中心の体験を提供するよう促しています。こうした期待の進化は、製品開発、臨床ワークフロー、そして現代医療における精密診断の全体的な位置づけに影響を与えています。

精密診断市場の成長は、いくつかの要因によって牽引されています。

精密診断市場の成長は、腫瘍学、心臓病学、神経学、感染症学における診断技術の応用拡大から始まるいくつかの要因によって牽引されています。実用的な遺伝子変異やバイオマーカーを特定できるようになったことで、臨床医は治療を調整し、治療効果をより正確にモニタリングできるようになりました。これは、標的治療が標準治療となりつつあるがん治療において特に重要です。

もう一つの大きな推進力は、先進的診断技術のコストと複雑さが軽減され、診療所や検査機関、さらには消費者にとっても、より利用しやすくなっていることです。診断と電子カルテ、臨床判断支援ツール、個別化治療アルゴリズムとの統合は、医療連携を強化し、誤診を減らしています。さらに、医療技術革新への投資の増加と個別化医療への制度的支援が、次世代診断プラットフォームの開発と展開を促進しています。これらの要因を総合すると、精密診断はヘルスケアの未来を変革する力として位置づけられています。

セグメント

検査タイプ（遺伝子検査、消費者向け直接検査、エソテリック検査、その他検査タイプ）、用途（腫瘍学用途、呼吸器疾患用途、皮膚疾患用途、中枢神経疾患用途、免疫学用途、遺伝子疾患用途、その他用途）、最終用途（臨床検査室最終用途、病院最終用途、その他最終用途）

調査対象企業の例

• Abbott Laboratories
• Agilent Technologies Inc.
• Bayer AG
• Becton, Dickinson and Company
• bioMerieux SA
• Danaher Corporation
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd
• Guardant Health
• Hologic, Inc.
• Illumina, Inc.
• Koninklijke Philips N.V.
• Lantheus Holdings, Inc.
• Myriad Genetics, Inc.
• Novartis AG
• PerkinElmer, Inc.
• QIAGEN N.V.
• Siemens Healthineers AG
• Swiss Precision Diagnostics GmbH
• Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Precision Diagnostics Market to Reach US$49.8 Billion by 2030

The global market for Precision Diagnostics estimated at US$18.2 Billion in the year 2024, is expected to reach US$49.8 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2024-2030. Genetic Tests, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$26.3 Billion by the end of the analysis period. Growth in the Direct to Consumer Tests segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 24.3% CAGR

The Precision Diagnostics market in the U.S. is estimated at US$5.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 24.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.4% and 16.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global Precision Diagnostics Market - Key Trends & Drivers Summarized

Why Is Precision Diagnostics Reshaping the Future of Healthcare?

Precision diagnostics refers to a set of advanced medical technologies that enable highly accurate disease detection, often at the molecular or genetic level. Unlike traditional diagnostic methods, precision diagnostics focuses on individual variability in genes, lifestyle, and environment to tailor diagnosis and treatment strategies to each patient. This shift allows for earlier disease identification, better risk stratification, and more personalized care pathways, significantly improving patient outcomes and reducing treatment inefficiencies.

The increasing global incidence of complex diseases such as cancer, cardiovascular conditions, and autoimmune disorders has accelerated the demand for more sophisticated diagnostic tools. As healthcare systems evolve toward prevention and value-based care, precision diagnostics is emerging as a cornerstone of this transformation. Its role in early detection, prognosis, and monitoring is not only reducing disease burden but also enabling timely intervention, which is especially critical for chronic and life-threatening conditions.

How Are Technological Advancements and Consumer Expectations Influencing the Market?

Technological innovation is rapidly advancing the precision diagnostics landscape. The growing capabilities of genomic sequencing, molecular profiling, and biomarker analysis have made it possible to detect diseases at their earliest and most treatable stages. Tools powered by artificial intelligence and machine learning are now enhancing pattern recognition, automating data interpretation, and supporting real-time clinical decision-making. These breakthroughs are expanding the scope and speed of diagnostics, making them more effective and scalable.

At the same time, consumer behavior is shaping how precision diagnostics are being designed and delivered. Today’s patients are more health-literate, data-conscious, and proactive about personalized health solutions. There's growing interest in non-invasive testing options such as liquid biopsies, wearable health devices, and home-based test kits. This shift is pushing healthcare providers and diagnostics companies to deliver more user-centric experiences that combine accuracy, speed, convenience, and privacy. These evolving expectations are influencing product development, clinical workflows, and the overall positioning of precision diagnostics in modern medicine.

The Growth in the Precision Diagnostics Market Is Driven by Several Factors……

The growth in the precision diagnostics market is driven by several factors, starting with the expanding application of diagnostic technologies across oncology, cardiology, neurology, and infectious diseases. The ability to identify actionable genetic mutations and biomarkers is enabling clinicians to tailor therapies and monitor treatment effectiveness with greater precision. This is particularly crucial in cancer treatment, where targeted therapies are becoming standard practice.

Another major driver is the reduction in cost and complexity of advanced diagnostic technologies, making them more accessible to clinics, labs, and even consumers. The integration of diagnostics with electronic health records, clinical decision support tools, and personalized treatment algorithms is enhancing care coordination and reducing misdiagnoses. Additionally, rising investment in health innovation and institutional support for personalized medicine is fostering the development and deployment of next-generation diagnostic platforms. Collectively, these factors are positioning precision diagnostics as a transformative force in the future of healthcare.

SCOPE OF STUDY:

The report analyzes the Precision Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Genetic Tests, Direct to Consumer Tests, Esoteric Tests, Other Test Types); Application (Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application, Immunology Application, Genetic Diseases Application, Other Applications); End-Use (Clinical Laboratories End-Use, Hospitals End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Agilent Technologies Inc.
• Bayer AG
• Becton, Dickinson and Company
• bioMerieux SA
• Danaher Corporation
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd
• Guardant Health
• Hologic, Inc.
• Illumina, Inc.
• Koninklijke Philips N.V.
• Lantheus Holdings, Inc.
• Myriad Genetics, Inc.
• Novartis AG
• PerkinElmer, Inc.
• QIAGEN N.V.
• Siemens Healthineers AG
• Swiss Precision Diagnostics GmbH
• Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Precision Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Personalized Medicine Accelerates Growth in Precision Diagnostics
  • Surge in Chronic Disease Prevalence Drives Adoption of Precision Diagnostics Technologies
  • Technological Advancements in Genomic Sequencing Propel Growth in Precision Diagnostics Market
  • Rising Popularity of Preventive Healthcare Strengthens Business Case for Early Detection and Diagnostic Solutions
  • Integration of Artificial Intelligence in Diagnostics Expands Market Opportunities for Precision Diagnostics
  • Increasing Focus on Minimally Invasive Diagnostic Techniques Drives Adoption of Precision Diagnostics Solutions
  • Growing Demand for Point-of-Care Diagnostics Expands the Reach of Precision Diagnostic Technologies
  • Regulatory Support for Early Disease Detection Strengthens Demand for Precision Diagnostics in Healthcare Systems
  • Rising Healthcare Expenditure Globally Creates Growth Opportunities for Advanced Diagnostic Solutions
  • Growing Awareness of the Benefits of Precision Medicine and Targeted Treatments Drives Demand for Diagnostic Tools
  • Expansion of Healthcare Infrastructure in Emerging Markets Generates New Opportunities for Precision Diagnostics
  • Increasing Focus on Precision Diagnostics in Oncology Propels Market Growth in Cancer Detection and Monitoring
  • Surge in the Development of Companion Diagnostics Drives Growth in the Precision Diagnostics Market
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Precision Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Precision Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Genetic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Direct to Consumer Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Direct to Consumer Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Direct to Consumer Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Esoteric Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Genetic Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Respiratory Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Skin Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Skin Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Skin Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for CNS Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for CNS Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for CNS Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Immunology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Immunology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Immunology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Precision Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Precision Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Precision Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Precision Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION